FDA releases CRISPR medicine framework for personalized gene therapies, building on Baby KJ's case. Danaher's Kassim flags ...

For­ma­tion Bio, an AI-fo­cused biotech that ac­quires out­side as­sets, de­vel­ops them and then hands them off, has raised ...

HHS on Wednes­day said it will stop en­forc­ing a ban on the com­pound­ing of cer­tain pop­u­lar pep­tides used for well­ness ...

Pfizer’s flood-damaged Gujarat cancer drug plant won’t resupply until 2028, deepening US chemotherapy shortages, ASHP said.

Astellas takes an option on Audax’s preclinical IL-12 drug DAX-044 for $285M upfront and option fees, plus up to $1.05B in ...

AstraZeneca delays a third lung cancer readout to 2027 after a run of trial failures, raising pressure on next year’s data.

How much ev­i­dence should the FDA re­quire be­fore it au­tho­rizes a gen­er­a­tive AI-en­abled med­ical de­vice? The ques­tion was a point of con­tention among health­care lob­by­ing ...

Zocdoc will let AI agents like Instinct and Google's Gemini book doctor appointments, ensuring verified doctors and insurance coverage.

Scientists are the biggest converts in Endpoints Signal’s Q3 survey, with 78% of them now saying they expect AI to boost drug discovery within a year.

Plowshare Therapies, led by Kevin Strauss, aims to develop a gene therapy for maple syrup urine disease, targeting ...

Anthropic buys Mithril Medicine, a one-person stealth biotech backed by Atlas whose founder ran the “Professor Oak” account ...

Gubra plans to expand beyond obesity into aging and I&I, targeting 8-10 clinical assets by 2030 and its first venture-built ...